PHENTERMINE HCL C-IV

Weight Management

Brand names: Phentermine HCL C-IV

Oral

Mechanism of Action

Other agent

Indications

Phentermine hydrochloride is indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise

behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index ≥ 30 kg/m 2

or ≥ 27 kg/m 2in the presence of other risk factors (e.g.

controlled hypertension

diabetes

hyperlipidemia). Below is a chart of body mass index (BMI) based on various heights and weights. BMI is calculated by taking the patient's weight

Contraindications

• History of cardiovascular disease (e.g.
• coronary artery disease
• stroke
• arrhythmias
• congestive heart failure

FDA Warnings

2 Primary Pulmonary Hypertension Primary Pulmonary Hypertension (PPH) – a rare, frequently fatal disease of the lungs has been reported to occur in patients receiving a combination of phentermine with fenfluramine or dexfenfluramine
3 Valvular Heart Disease Serious regurgitant cardiac valvular disease, primarily affecting the mitral, aortic and/or tricuspid valves, has been reported in otherwise healthy persons who had taken a combination of phentermine with fenfluramine or dexfenfluramine for weight loss
6 Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d/l-amphetamine) and to other related stimulant drugs that have been extensively abused
8 Use in Patients With Hypertension Use caution in prescribing phentermine for patients with even mild hypertension (risk of increase in blood pressure)

Known Side Effects

13 documented side effects by frequency

Headache

>10%

Nausea

1-10%

Drug Not Working

1-10%

Fatigue

1-10%

Anxiety

1-10%

Dizziness

1-10%

Weight Gain

1-10%

Insomnia

1-10%

Tingling/Numbness

1-10%

Constipation

1-10%

Depression

0.1-1%

Dry Mouth

0.1-1%

Vomiting

0.1-1%

Community Discussions

No community discussions found for PHENTERMINE HCL C-IV yet.

Compare With

3 available comparisons

Formulations

Dosage Forms

Tablet

Route

Oral